Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus

Jillian S Y Lau, Dilip Ratnam, Ian Woolley

Research output: Contribution to journalArticleOtherpeer-review

1 Citation (Scopus)

Abstract

Previously we found that local patients were often not tested for HIV prior to commencing nucleoside/nucleotide reverse transcription inhibitor (NRTI) therapy for hepatitis B virus. We performed a national cross-sectional cohort study of physician practices via an online survey. A small majority (23/44; 52%) of participants reported always testing their hepatitis B virus patients for HIV prior to NRTI therapy, and 8/44 (18%) reported testing for HIV the majority of the time. Thirteen (30%) respondents reported testing only if risk factors were present. One physician reported a patient seroconverting to HIV while on TDF monotherapy.

Original languageEnglish
Pages (from-to)89-90
Number of pages2
JournalSexual Health
Volume15
Issue number1
DOIs
Publication statusPublished - 2018

Cite this

@article{5f510e189e994aea9dacaa392644e993,
title = "Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus",
abstract = "Previously we found that local patients were often not tested for HIV prior to commencing nucleoside/nucleotide reverse transcription inhibitor (NRTI) therapy for hepatitis B virus. We performed a national cross-sectional cohort study of physician practices via an online survey. A small majority (23/44; 52{\%}) of participants reported always testing their hepatitis B virus patients for HIV prior to NRTI therapy, and 8/44 (18{\%}) reported testing for HIV the majority of the time. Thirteen (30{\%}) respondents reported testing only if risk factors were present. One physician reported a patient seroconverting to HIV while on TDF monotherapy.",
author = "Lau, {Jillian S Y} and Dilip Ratnam and Ian Woolley",
year = "2018",
doi = "10.1071/SH17045",
language = "English",
volume = "15",
pages = "89--90",
journal = "Sexual Health",
issn = "1448-5028",
publisher = "CSIRO",
number = "1",

}

Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus. / Lau, Jillian S Y; Ratnam, Dilip; Woolley, Ian.

In: Sexual Health, Vol. 15, No. 1, 2018, p. 89-90.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus

AU - Lau, Jillian S Y

AU - Ratnam, Dilip

AU - Woolley, Ian

PY - 2018

Y1 - 2018

N2 - Previously we found that local patients were often not tested for HIV prior to commencing nucleoside/nucleotide reverse transcription inhibitor (NRTI) therapy for hepatitis B virus. We performed a national cross-sectional cohort study of physician practices via an online survey. A small majority (23/44; 52%) of participants reported always testing their hepatitis B virus patients for HIV prior to NRTI therapy, and 8/44 (18%) reported testing for HIV the majority of the time. Thirteen (30%) respondents reported testing only if risk factors were present. One physician reported a patient seroconverting to HIV while on TDF monotherapy.

AB - Previously we found that local patients were often not tested for HIV prior to commencing nucleoside/nucleotide reverse transcription inhibitor (NRTI) therapy for hepatitis B virus. We performed a national cross-sectional cohort study of physician practices via an online survey. A small majority (23/44; 52%) of participants reported always testing their hepatitis B virus patients for HIV prior to NRTI therapy, and 8/44 (18%) reported testing for HIV the majority of the time. Thirteen (30%) respondents reported testing only if risk factors were present. One physician reported a patient seroconverting to HIV while on TDF monotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85041421555&partnerID=8YFLogxK

U2 - 10.1071/SH17045

DO - 10.1071/SH17045

M3 - Article

VL - 15

SP - 89

EP - 90

JO - Sexual Health

JF - Sexual Health

SN - 1448-5028

IS - 1

ER -